Background: In this prospective study, we assessed the performance of the Genotype MTBDRplus assay for the simultaneous identification of Mycobacterium tuberculosis complex (MTBC) and its ability for rapid detection of resistance to Isoniazid and Rifampin in sputum samples, compared to serveral weeks to months with conventional methods.